Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Quintiles

The future of Pfizer(s)

Current headlines point to a frightening journey

- PMLiVE

Mylan agrees to buy Sweden’s Meda for $7.2bn

Deal is set to boost its over-the-counter medicines portfolio 

- PMLiVE

Baxalta agrees to $32bn Shire takeover

Deal will  create one of the industry's top rare disease firms

Deal Watch December 2015

The month’s deals see a number of collaboration and licensing deals for technology platforms and new molecule discovery

- PMLiVE

Pharma sales in the digital era

A successful marketing strategy must embrace customer preferences and strive for a channel mix that provides the right information at the audience's convenience

Shire Basingstoke

Shire deal with Baxalta predicted this week

Takeover talks reported to be at an advanced stage

Deal Watch November 2015

Strategic business expansion or financial engineering?In November Pfizer at long last found a willing acquisition target that may provide the tax inversion it has been desperate to achieve since its...

- PMLiVE

Quintiles wins New Models of Care award at PMEA

Rewarded for its rheumatology project for Pfizer

Deal Watch October 2015

A bumper crop of deals with seven transactions of $1bn or more

- PMLiVE

Pfizer and Allergan merger faces opposition over tax

Companiesagree deal to boost Pfizer's standing as world's largest pharma company

- PMLiVE

Quintiles founder Dr Dennis Gillings to retire as chairman

He will be replacedin that role by Jack Greenberg

- PMLiVE

Mylan misses Perrigo takeover deadline

Failureto take 50% stake ends near-term hopes for a bid

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links